Elizabeth Widmer
Medical · Fort Worth, TXNPI 1336562883
Payments from drug & device makers
Across 641 payments — averaging $22.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Dermavant Sciences, Inc.$2K
- Journey Medical Corporation$1K
- Arcutis Biotherapeutics, Inc.$1K
- Galderma Laboratories, L.p.$900
- Mayne Pharma Commercial LLC$872
- plus $6K from 27 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 87 | $1,992 |
| Dermavant Sciences, Inc. | 53 | $1,778 |
| Journey Medical Corporation | 11 | $1,440 |
| Arcutis Biotherapeutics, Inc. | 95 | $1,186 |
| Galderma Laboratories, L.p. | 57 | $900 |
| Mayne Pharma Commercial LLC | 63 | $872 |
| Sun Pharmaceutical Industries Inc. | 43 | $858 |
| Incyte Corporation | 29 | $835 |
| Sanofi | 23 | $606 |
| Novartis | 25 | $501 |
| Pfizer | 31 | $469 |
| Regeneron Healthcare Solutions, Inc. | 18 | $400 |
| Lilly USA, LLC | 16 | $356 |
| UCB, Inc. | 8 | $348 |
| LEO Pharma Inc. | 14 | $261 |
| VYNE Pharmaceuticals Inc. | 7 | $245 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 14 | $224 |
| E.r. Squibb & Sons, L.L.C. | 5 | $192 |
| Organon | 8 | $147 |
| Amgen | 6 | $137 |
| Medimetriks Pharmaceuticals, Inc. | 5 | $103 |
| Johnson & Johnson | 5 | $88 |
| Almirall LLC | 3 | $47 |
| Dermira, Inc. | 3 | $47 |
| Boehringer Ingelheim | 2 | $42 |
| Genentech USA, Inc. | 2 | $40 |
| Misonix Inc | 2 | $25 |
| Merz North America, Inc. | 1 | $24 |
| Cipher Pharmaceuticals US LLC | 1 | $19 |
| Biofrontera Inc. | 1 | $18 |
| Nabriva Therapeutics, PLC | 1 | $17 |
| Botanix SB Inc | 1 | $15 |
| Boston Scientific | 1 | $15 |
How this compares
$14,248 in reported general payments places this provider in the 95th percentile of 1,490 medical providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other medical in Fort Worth
- Mark DavisFort Worth$1M
- Francesca FongFort Worth$25K
- Jose de la CerdaSan Antonio$1.1M
- Joey Dixon-JulianBoerne$458K
- Terry FaleyeKingwood$243K
- Kimberly PoarchDallas$166K
- Erin DuhaimeDallas$150K
- Courtney AldridgeSan Antonio$129K
- Shakira CabreraSan Antonio$116K
- Danny DeckardDallas$101K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.